Clinical efficacy of eprosartan

Pharmacotherapy

Volumn 19, Issue 4 II, 1999, Pages

  Weber, Michael ^a  

^a BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ENALAPRIL; EPROSARTAN; LOSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE CALCULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0032923579     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.7.95s.30950     Document Type: Review

References (12)

1. Hedner T, Samuelsson D, Lunde H, Lindholm L, Andren L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1992;304:941-6.
2. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-42.
3. Lunde H, Hedner T, Samuelsson D, et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1994;308:18-21.
4. Edwards RM, Aiyar N, Ohlstein EH, et al. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566. J Pharmacol Exp Ther 1992;260:175-81.
5. Gradman AH, Gray J, Maggiacomo F, et al. Evaluation of the novel angiotensin II antagonist, eprosartan, used once daily in patients with systemic hypertension. Clin Ther In press.
6. Hedner T, Himmelmann A, for the Eprosartan Multinational Study Group. The efficacy and tolerance of one and two daily doses of eprosartan in essential hypertension. J Hypertens 1999;17(1):129-36.
7. Elliot W. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. J Hum Hypertens In press.
8. Argenziano L, Trimarco B. Effect of eprosartan and enalapril in treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Curr Med Res Opin 1999;15(1):9-14.
9. Levine B. Effect of eprosartan and enalapril in treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Curr Med Res Opin 1999;15(1):25-32.
10. Oparil S. Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough. Curr Ther Res 1999;60 (1):1-14.
11. Ponticelli C, for the Eprosartan Study Group. Comparison of the efficacy of eprosartan and enalapril in patients with severe hypertension. Am J Hypertens 1997;10:128A.
12. Garcia Puig J, Mateos Anton F, et al. Evaluation of uric acid excretion and blood pressure in patients with essential hypertension treated with eprosartan and losartan [abstr]. J Hypertens 1998;16(suppl 2):S316.